Pilot Testing Dementia-Enhanced Training and Tool for Home Hospice Clinicians (NCT05719077) | Clinical Trial Compass
CompletedNot Applicable
Pilot Testing Dementia-Enhanced Training and Tool for Home Hospice Clinicians
United States93 participantsStarted 2023-10-06
Plain-language summary
The purpose of this study is to pilot test the feasibility, acceptability, and preliminary efficacy of a clinically useful, inclusive dementia-enhanced training and tool for use by home hospice clinicians to improve care and support for Black and White patients with dementia and their family caregivers. The investigators expect family caregivers of clinicians in the intervention group will report less caregiver burden (primary outcome) than caregivers of clinicians in the control group. The investigators expect that, compared to clinicians in the control group (usual care), clinicians in the intervention group (receive the training and use the tool) will demonstrate more knowledge of dementia-related caregiving issues (secondary outcomes). In exploratory analyses, the investigators expect family caregivers will report greater self-efficacy and preparedness, and that patients of clinicians in the intervention group will experience fewer live discharges than family caregivers of patients of clinicians in the control group.
Who can participate
Age range
19 Years – 90 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Individuals are not excluded from this study based on gender.
* Based on proportion of hospice workforce and family caregivers that are female, we expect 70%-80% of participants will be female.
* Nurse, social worker, or family member who provides care to persons(s) living with dementia enrolled in home hospice care.
* 19-90 years old.
* Can complete data collection in English.
* Family Caregivers: identify as White or Black/African American.
Exclusion Criteria:
* Participant is less than 19 years old or older than 90 years old.
* Does not provide care to person(s) living with dementia enrolled in home hospice.
* Cannot complete data collection in English.
* Family Caregiver does not identify as White or Black/African American.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Family Caregiver Burden
Timeframe: Baseline and through first subsequent hospice visit, an average of 8 weeks
Trial details
NCT IDNCT05719077
SponsorRutgers, The State University of New Jersey